153 related articles for article (PubMed ID: 20848232)
1. Visfatin stimulates proliferation of MCF-7 human breast cancer cells.
Kim JG; Kim EO; Jeong BR; Min YJ; Park JW; Kim ES; Namgoong IS; Kim YI; Lee BJ
Mol Cells; 2010 Oct; 30(4):341-5. PubMed ID: 20848232
[TBL] [Abstract][Full Text] [Related]
2. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
3. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways.
Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F
Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926
[TBL] [Abstract][Full Text] [Related]
4. A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis.
Patel ST; Mistry T; Brown JE; Digby JE; Adya R; Desai KM; Randeva HS
Peptides; 2010 Jan; 31(1):51-7. PubMed ID: 19819277
[TBL] [Abstract][Full Text] [Related]
5. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells.
Ninomiya S; Shimizu M; Imai K; Takai K; Shiraki M; Hara T; Tsurumi H; Ishizaki S; Moriwaki H
Cancer Prev Res (Phila); 2011 Dec; 4(12):2092-100. PubMed ID: 21952585
[TBL] [Abstract][Full Text] [Related]
6. Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells.
Gholinejad Z; Kheiripour N; Nourbakhsh M; Ilbeigi D; Behroozfar K; Hesari Z; Golestani A; Shabani M; Einollahi N
Peptides; 2017 Jun; 92():9-15. PubMed ID: 28442350
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Effects of Resistin and Visfatin as Adipocyte Derived Hormones on Telomerase Gene Expression in AGS Gastric Cancer Cell Line.
Mohammadi M; Zarghami N; Hedayati M; Ghaemmaghami S
Acta Med Iran; 2017 Oct; 55(10):621-627. PubMed ID: 29228527
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells: its role in MMP-2/9 production and activation.
Adya R; Tan BK; Chen J; Randeva HS
Diabetes Care; 2008 Apr; 31(4):758-60. PubMed ID: 18184904
[TBL] [Abstract][Full Text] [Related]
10. Extracellular NAMPT/visfatin causes p53 deacetylation via NAD production and SIRT1 activation in breast cancer cells.
Behrouzfar K; Alaee M; Nourbakhsh M; Gholinejad Z; Golestani A
Cell Biochem Funct; 2017 Aug; 35(6):327-333. PubMed ID: 28845527
[TBL] [Abstract][Full Text] [Related]
11. Exogenous administration of visfatin affects cytokine secretion and increases oxidative stress in human malignant melanoma Me45 cells.
Buldak RJ; Polaniak R; Buldak L; Mielanczyk L; Kukla M; Skonieczna M; Dulawa-Buldak A; Matysiak N; Zwirska-Korczala K
J Physiol Pharmacol; 2013 Jun; 64(3):377-85. PubMed ID: 23959735
[TBL] [Abstract][Full Text] [Related]
12. Visfatin Triggers the Cell Motility of Non-Small Cell Lung Cancer via Up-Regulation of Matrix Metalloproteinases.
Wang G; Tian W; Liu Y; Ju Y; Shen Y; Zhao S; Zhang B; Li Y
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):548-554. PubMed ID: 27224551
[TBL] [Abstract][Full Text] [Related]
13. Visfatin triggers the in vitro migration of osteosarcoma cells via activation of NF-κB/IL-6 signals.
Wang GJ; Shen NJ; Cheng L; Yehan Fang ; Huang H; Li KH
Eur J Pharmacol; 2016 Nov; 791():322-330. PubMed ID: 27568842
[TBL] [Abstract][Full Text] [Related]
14. Visfatin induces stromal cell-derived factor-1 expression by β1 integrin signaling in colorectal cancer cells.
Huang WS; Chen CN; Sze CI; Teng CC
J Cell Physiol; 2013 May; 228(5):1017-24. PubMed ID: 23042611
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the differential physiological effects of adipocytokines visfatin and resistin in liver cancer cells.
Miethe C; Zamora M; Torres L; Raign KG; Groll CJ; Price RS
Horm Mol Biol Clin Investig; 2019 Mar; 38(2):. PubMed ID: 30917102
[TBL] [Abstract][Full Text] [Related]
16. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion.
Kim SR; Park HJ; Bae YH; Ahn SC; Wee HJ; Yun I; Jang HO; Bae MK; Bae SK
Endocrinology; 2012 Feb; 153(2):554-63. PubMed ID: 22186408
[TBL] [Abstract][Full Text] [Related]
17. Visfatin promotes the malignancy of human acute myeloid leukemia cells via regulation of IL-17.
Hui Z; Liu Z; He A; Chen Y; Zhang P; Lei B; Yao H; Yu Y; Liang R; Li Z; Zhang W
Eur J Pharmacol; 2019 Jun; 853():103-110. PubMed ID: 30876976
[TBL] [Abstract][Full Text] [Related]
18. Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study.
Bułdak RJ; Bułdak Ł; Polaniak R; Kukla M; Birkner E; Kubina R; Kabała-Dzik A; Duława-Bułdak A; Żwirska-Korczala K
Oncol Rep; 2013 Feb; 29(2):771-8. PubMed ID: 23232726
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
Watts CK; Sweeney KJ; Warlters A; Musgrove EA; Sutherland RL
Breast Cancer Res Treat; 1994; 31(1):95-105. PubMed ID: 7981461
[TBL] [Abstract][Full Text] [Related]
20. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
Musgrove EA; Hamilton JA; Lee CS; Sweeney KJ; Watts CK; Sutherland RL
Mol Cell Biol; 1993 Jun; 13(6):3577-87. PubMed ID: 8497271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
